Health Alert:

Joslin is following the events with regard to the Coronavirus (2019-nCoV). For the health and safety of our patients, visitors, and staff we are following recommendations of the Massachusetts Department of Public Health and the Centers for Disease Control. Those agencies are reporting a low risk for people in the United States to contract Coronavirus but encourage these prevention practices.

Alert Close

Since joining the Beetham Eye Institute (BEI) in 1982, Dr. Arrigg has devoted his professional career to providing diabetes eye care with particular emphasis on vitreo-retinal disease and surgery.  Dr. Arrigg is currently an Associate Professor, Department of Ophthalmology, Harvard Medical School, and Chief of Vitreo-Retinal Surgery at the BEI.  As part of his clinical and surgical practice, Dr. Arrigg has access to the latest diagnostic and treatment modalities while performing approximately 150 vitrectomy surgeries per year and conducting multiple intravitreous injection clinics for diabetic macular edema, diabetic retinopathy and macular degeneration. 

Dr. Arrigg is a co-investigator for Diabetic Retinopathy Clinical Research Network (DRCR.net) studies conducted at the BEI and he has been an active participant in numerous federally funded and privatedly funded clinical research studies and trials, including the Diabetes Control and Complication Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) study and numerous trials conducted at the Dana-Farber Cancer Institute.

Contact Information

Office Phone

(617) 309-2552